Xenon Pharmaceuticals Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -36.0% | -36.0% | -34.1% |
| FY2017 | -85.4% | -73.0% | -66.6% |
| FY2018 | -33.4% | -29.2% | -28.2% |
| FY2019 | -45.2% | -40.4% | -28.2% |
| FY2020 | -16.8% | -16.8% | -15.2% |
| FY2021 | -14.3% | -14.3% | -13.8% |
| FY2022 | -17.4% | -17.4% | -16.6% |
| FY2023 | -19.7% | -19.7% | -18.9% |
| FY2024 | -31.0% | -31.0% | -29.4% |
| FY2025 | -59.5% | -59.5% | -54.6% |